Literature DB >> 17218421

Increased Notch 1 expression and attenuated stimulatory G protein coupling to adenylyl cyclase in osteonectin-null osteoblasts.

Catherine B Kessler1, Anne M Delany.   

Abstract

Osteonectin, or secreted protein acidic and rich in cysteine, is one of the most abundant noncollagen matrix components in bone. This matricellular protein regulates extracellular matrix assembly and maturation in addition to modulating cell behavior. Mice lacking osteonectin develop severe low-turnover osteopenia, and in vitro studies of osteonectin-null osteoblastic cells showed that osteonectin supports osteoblast formation, maturation, and survival. The present studies demonstrate that osteonectin-null osteoblastic cells have increased expression of Notch 1, a well-documented regulator of cell fate in multiple systems. Furthermore, osteonectin-null cells are more plastic and less committed to osteoblastic differentiation, able to pursue adipogenic differentiation given the appropriate signals. Notch 1 transcripts are down-regulated by inducers of cAMP in both wild-type and osteonectin-null osteoblasts, suggesting that the mutant osteoblasts may have a defect in generation of cAMP in response to stimuli. Indeed, many bone anabolic agents signal through increased cAMP. Wild-type and osteonectin-null osteoblasts generated comparable amounts of cAMP in response to forskolin, a direct stimulator of adenylyl cyclase. However, the ability of osteonectin-null osteoblasts to generate cAMP in response to cholera toxin, a direct stimulator of Gs, was attenuated. These data imply that osteonectin-null osteoblasts have decreased coupling of Gs to adenylyl cyclase. Because osteonectin promotes G protein coupling to an effector, our studies support the concept that low-turnover osteopenia can result from reducing G protein coupled receptor activity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17218421     DOI: 10.1210/en.2006-0443

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  13 in total

1.  miR-29 suppression of osteonectin in osteoblasts: regulation during differentiation and by canonical Wnt signaling.

Authors:  Kristina Kapinas; Catherine B Kessler; Anne M Delany
Journal:  J Cell Biochem       Date:  2009-09-01       Impact factor: 4.429

Review 2.  SPARC: a key player in the pathologies associated with obesity and diabetes.

Authors:  Katarina Kos; John P H Wilding
Journal:  Nat Rev Endocrinol       Date:  2010-03-02       Impact factor: 43.330

3.  Bone matrix osteonectin limits prostate cancer cell growth and survival.

Authors:  Kristina Kapinas; Katie M Lowther; Catherine B Kessler; Karissa Tilbury; Jay R Lieberman; Jennifer S Tirnauer; Paul Campagnola; Anne M Delany
Journal:  Matrix Biol       Date:  2012-04-16       Impact factor: 11.583

Review 4.  Notch: A multi-functional integrating system of microenvironmental signals.

Authors:  Bryce LaFoya; Jordan A Munroe; Masum M Mia; Michael A Detweiler; Jacob J Crow; Travis Wood; Steven Roth; Bikram Sharma; Allan R Albig
Journal:  Dev Biol       Date:  2016-08-24       Impact factor: 3.582

5.  Accentuated osteoclastic response to parathyroid hormone undermines bone mass acquisition in osteonectin-null mice.

Authors:  Luciene Machado do Reis; Catherine B Kessler; Douglas J Adams; Joseph Lorenzo; Vanda Jorgetti; Anne M Delany
Journal:  Bone       Date:  2008-04-13       Impact factor: 4.398

Review 6.  Notch signaling and the bone marrow hematopoietic stem cell niche.

Authors:  Jonathan M Weber; Laura M Calvi
Journal:  Bone       Date:  2009-08-11       Impact factor: 4.398

7.  Osteonectin/SPARC polymorphisms in Caucasian men with idiopathic osteoporosis.

Authors:  A M Delany; D J McMahon; J S Powell; D A Greenberg; E S Kurland
Journal:  Osteoporos Int       Date:  2007-12-15       Impact factor: 4.507

8.  Periostin associates with Notch1 precursor to maintain Notch1 expression under a stress condition in mouse cells.

Authors:  Hideyuki Tanabe; Issei Takayama; Takashi Nishiyama; Masashi Shimazaki; Isao Kii; Minqi Li; Norio Amizuka; Ken-ichi Katsube; Akira Kudo
Journal:  PLoS One       Date:  2010-08-18       Impact factor: 3.240

9.  Thrombospondin-2 and SPARC/osteonectin are critical regulators of bone remodeling.

Authors:  Anne M Delany; Kurt David Hankenson
Journal:  J Cell Commun Signal       Date:  2009-10-28       Impact factor: 5.782

10.  Granzyme B-induced neurotoxicity is mediated via activation of PAR-1 receptor and Kv1.3 channel.

Authors:  Tongguang Wang; Myoung-Hwa Lee; Elliot Choi; Carlos A Pardo-Villamizar; Sung Bin Lee; In Hong Yang; Peter A Calabresi; Avindra Nath
Journal:  PLoS One       Date:  2012-08-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.